Google News – Clinical Trials External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)? - simplywall.st
Google News – Pharmaceuticals External News
Trump brings nine mid-sized drugmakers into the MFN fold - FirstWord Pharma
Google News – Pharmaceuticals External News
New research could improve detection of chiral molecules in pharmaceuticals, biotechnology - Ohio University
Google News – Pharmaceuticals External News
Jazz Pharmaceuticals Raises $1.25 Billion Via 1.875% Exchangeable Notes Due 2032 - TradingView
Google News – Pharmaceuticals External News
Trump announces drug pricing deals with nine pharmaceutical firms - Investing.com
Google News – Pharmaceuticals External News
MFN Program Grows to 26 Drugmakers as Nine More Commit to $19.6B in US Manufacturing - Pharmaceutical Commerce
Google News – Pharmaceuticals External News
White House unveils next round of MFN pricing deals with 9 midsized drugmakers - Fierce Pharma
Google News – Pharmaceuticals External News
WATCH: Trump says more pharmaceutical companies will lower drug prices - PBS
Google News – Biopharma External News
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Google News – Pharmaceuticals External News
Jazz Pharmaceuticals (NASDAQ: JAZZ) director to sell 1,527 shares in 2026 - Stock Titan
Google News – Pharmaceuticals External News
PMV Pharmaceuticals (PMVP) Launches Public Offering Amid Unprofi - GuruFocus
Google News – Pharmaceuticals External News
PMV Pharmaceuticals (PMVP) Updates Interim Ovarian Cancer Trial Results Amid Valuation Challenges - GuruFocus
Google News – Pharmaceuticals External News
Jazz Pharmaceuticals (NASDAQ: JAZZ) director to sell 3,507 shares - Stock Titan
Google News – Pharmaceuticals External News

